Your browser doesn't support javascript.
loading
A phase II study of axitinib in advanced neuroendocrine tumors.
Strosberg, J R; Cives, M; Hwang, J; Weber, T; Nickerson, M; Atreya, C E; Venook, A; Kelley, R K; Valone, T; Morse, B; Coppola, D; Bergsland, E K.
Afiliação
  • Strosberg JR; Department of Gastrointestinal OncologyH. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA jonathan.strosberg@moffitt.org.
  • Cives M; Department of Gastrointestinal OncologyH. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.
  • Hwang J; Department of Medicine and The UCSF Helen Diller Family Comprehensive Cancer CenterUniversity of California, San Francisco, California, USA.
  • Weber T; Department of Medicine and The UCSF Helen Diller Family Comprehensive Cancer CenterUniversity of California, San Francisco, California, USA.
  • Nickerson M; Department of Medicine and The UCSF Helen Diller Family Comprehensive Cancer CenterUniversity of California, San Francisco, California, USA.
  • Atreya CE; Department of Medicine and The UCSF Helen Diller Family Comprehensive Cancer CenterUniversity of California, San Francisco, California, USA.
  • Venook A; Department of Medicine and The UCSF Helen Diller Family Comprehensive Cancer CenterUniversity of California, San Francisco, California, USA.
  • Kelley RK; Department of Medicine and The UCSF Helen Diller Family Comprehensive Cancer CenterUniversity of California, San Francisco, California, USA.
  • Valone T; Department of Gastrointestinal OncologyH. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.
  • Morse B; Department of Gastrointestinal OncologyH. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.
  • Coppola D; Department of Gastrointestinal OncologyH. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.
  • Bergsland EK; Department of Medicine and The UCSF Helen Diller Family Comprehensive Cancer CenterUniversity of California, San Francisco, California, USA.
Endocr Relat Cancer ; 23(5): 411-8, 2016 05.
Article em En | MEDLINE | ID: mdl-27080472

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tumores Neuroendócrinos / Inibidores de Proteínas Quinases / Imidazóis / Indazóis / Antineoplásicos Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tumores Neuroendócrinos / Inibidores de Proteínas Quinases / Imidazóis / Indazóis / Antineoplásicos Idioma: En Ano de publicação: 2016 Tipo de documento: Article